Thompson Siegel & Walmsley’s Argan AGX Stock Holding History

Thompson Siegel & Walmsley’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9	Closed	–	–	850
2016 Q4	$0	Buy	+9	New	+$562	﹤0.01%	873

Other funds holding AGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Thompson Siegel & Walmsley's AGX Position: Q1 2017 in Review

Thompson Siegel & Walmsley sold out of Argan (AGX) in Q1 2017, closing a stake of 9 shares.

Thompson Siegel & Walmsley first reported a position in AGX in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 194 funds tracked by Wall St. Rank hold AGX as of Q1 2017.

Thompson Siegel & Walmsley reported no remaining Argan position as of Q1 2017 after selling out during the quarter.
Thompson Siegel & Walmsley sold 9 Argan shares in Q1 2017.
Thompson Siegel & Walmsley first reported a position in Argan in Q4 2016 and held it in 1 quarter.
Thompson Siegel & Walmsley's Argan position peaked at $0 in Q4 2016.
194 funds tracked by Wall St. Rank held Argan as of Q1 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2017, filed 15 May 2017.